Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Financing Activities ratio of GLAND PHARMA is ₹-433 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-433 Cr
Mar2024₹-799 Cr
Mar2023₹15 Cr
Mar2022₹35 Cr
Mar2021₹1,238 Cr

How is Cash Flow from Financing Activities of GLAND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-433 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹15 Cr
-57.25
Mar2022 ₹35 Cr
-97.18
Mar2021 ₹1,238 Cr -

Compare Cash Flow from Financing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹36,315.7 Cr -2.7% -2.1% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,639.0 Cr 0.9% -3.1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹179,647.0 Cr 2% -2.1% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,366.0 Cr -2.9% -0.3% 36.4% Stock Analytics
CIPLA ₹109,528.0 Cr -2.4% -3.8% -10.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,819.0 Cr -0.5% -5% -6.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.7%

-2.1%

31.8%

SENSEX

4.9%

2.8%

-6.2%


You may also like the below Video Courses